U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research (CDER)
  5. CDER Offices and Divisions
  6. Office of the Center Director
  1. CDER Offices and Divisions

Office of the Center Director

Who We Are

The Office of the Center Director provides leadership and overall direction to all CDER activities to ensure that the mission of the Center is accomplished. CDER makes sure that high-quality, safe and effective drugs are available to improve the health of consumers. CDER ensures that prescription and over-the-counter drugs, both brand name and generic, work correctly and that the health benefits outweigh known risks.  

What We Do

  • Identify, track, oversee, and establish policies regarding the management of important drug safety issues.
  • Track emerging safety issues and ensuring that they are resolved in a timely manner.
  • Provide scientific and regulatory leadership and guidance for responding to public health emergencies involving drugs that may pose an immediate threat to the public health.
  • Collaborate with the public and private sectors to address issues of interest, including strategies for ensuring safe medication use.
  • Lead the Center’s drug development initiatives related to terror and military counter-terrorism measures.
  • Lead CDER responses to public health emergencies (e.g., pandemic influenza, and disasters) or to counteract the effects of a terrorist event.
  • Facilitate the development and availability of medical countermeasures to chemical, biological, and other threats.
  • Develop policies and procedures governing the management and prevention of drug shortages.

Office Organization

Contact Us

Email: druginfo@fda.hhs.gov | Telephone: 301-796-5400 | Fax: 301-595-7910

Office of the Center Director, Center for Drug Evaluation and Research, White Oak Building 51, 6th Floor, 10903 New Hampshire Avenue, Silver Spring, MD 20993



Back to Top